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Objective: To study the involvement of MAPK MEK/ERK signaling transduction
pathway in the apoptosis process of SW620 tumor cell line and the inhibition effect of
resveratrol.
Methods: SW620 cell lines were divided into 5 groups, namely, control group, PD98059
group, low-dose resveratrol group, mid-dose resveratrol group and high-dose resveratrol
group. The inhibition rate of cell proliferation was detected by MTT method. The
expression of apoptotic molecules and MEK/ERK signaling pathway related proteins
were assayed by real-time PCR and Western blotting.
Results: Compared with control group, the proliferation of cells treated with resveratrol
was signiﬁcantly inhibited. In the case of apoptotic molecules, the expression of Bax,
Caspase 3 and Caspase 9 was increased signiﬁcantly while the expression of anti-
apoptotic molecule Bcl2 was decreased signiﬁcantly in resveratrol groups with a dose-
dependent manner. In the case of molecules in MEK/ERK signaling pathway, the
expression of Ras, Raf, MEK and ERK1/2 was decreased signiﬁcantly in resveratrol
groups with a dose-dependent manner.
Conclusions: PD98059 and resveratrol can effectively inhibit the proliferation of SW620
through inhibiting the MEK/ERK signaling pathway.1. Introduction
The colon cancer is one of the most clinically common ma-
lignant tumors in digestive tract, seriously affecting patients'
health and heavily burdening both patients' family and society
economically and socially [1,2]. The early stage of colon cancer
is presented as abdominal distension and dyspepsia while
abdominal pain before defecation, mucous stool, mucopurulent
stool, anemia, feebleness, emaciation, edema and other toxic
symptoms are presented in the later stage [3,4]. However, the
speciﬁc pathogenesis of colon cancer still remains unveiled
and there have been no effective therapeutic drugs clinically
yet. MEK/ERK signaling transduction pathway is the key
pathway of extracellular signal being transduced into cells and
furthermore transduction of karyo gene being activated, withparticipation in sorts of pathological processes and close
relation to occurrence, development and deterioration of
tumors [5,6]. The present study analyzed the mechanism of
MEK/ERK signaling pathway in the apoptosis of SW620 cells
and the inhibition effect of resveratrol on cell proliferation,
aiming to provide reference for clinical treatments to patients
with colon cancer and research and development relative to
anti-colon cancer new drugs.
2. Materials and methods
2.1. Reagents and equipments
The human colon cancer cell line SW620 was purchased
from Institutes of Cell Biology, Chinese Academy of Sciences.
The Dulbecco's modiﬁed eagle medium was purchased from
Gbico Company, USA. Fetal calf serum was purchased from
Wuhan Procell Biological Technology Co., LTD. Dimethyl
sulfoxide (DMSO) was purchased from China National Phar-
maceutical Corporation. Trypsin, 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2-H-tetrazolium bromide (MTT) and PD98059
were purchased from Sigma Aldrich Company, USA. mRNAle under the CC BY-NC-ND license (http://
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reverse transcriptase of quantitative real-time PCR was pur-
chased from Invitrogen Company. b-Actin and SYBR Premix
Ex Taq™Ⅱ were purchased from TaKaRa Company, Japan.
Caspase 3 and Caspase 9 monoclonal antibodies were pur-
chased from Abcam Company, USA. Ras and Raf monoclonal
antibodies were purchased from Santa Cruz Company, USA.
MEK and ERK1/2 antibody were purchased from Wuhan
BOSTER Bioengineering LTD. Second antibody marked with
horseradish peroxidase and diaminobenzidine color develop-
ment kit were purchased from Beijing ZSGB-Bio LTD. Cell
incubator was purchased from Shanghai Xinmiao Equipment
LTD. Light Cycler 480 real-time ﬂuorescent PCR was purchased
from Roche Company. Protein electrophoresis and transfer-
membrane system were purchased from ABI Company.
2.2. Grouping and medication
The SW620 cell lines were randomly divided into control
group, PD98095 group, low-dose resveratrol group, mid-dose
resveratrol group and high-dose resveratrol group. For
PD98095 group, PD98095 (10 mmol/L) was added for incuba-
tion. A total of 1, 10 and 100 mmmol/L resveratrol were given to
low-dose resveratrol group, mid-dose resveratrol group and
high-dose resveratrol group, respectively. In control group,
DMSO solvent was added for incubation.
2.3. Inhibition rate of proliferation by MTT assay
After the addition of relative medication and solvent for all
groups, under the conditions of 37 C, 5% CO2, 24, 36, 48 and
72 h incubation with saturated humidity, the culture solution was
abandoned and MTT was added into each well of cell incubation
plate before the continuous incubation in 5% CO2 for 4 h. Af-
terwards, DMSO was added into each well and shaken vigor-
ously on the oscillating table until complete dissolution. The
value of optical density (OD) in each well was detected by MTT
assay and the inhibition rate of cell proliferation was calculated
by using the formula as the follows: % inhibition rate = (OD1 −
OD2)/OD1 × 100. Where OD1 was the OD value in control
group and OD2 was the value in the other four experimental
groups.
2.4. Real-time PCR determination
The process of mRNA extraction and cDNA synthesis
strictly stuck to the speciﬁcation sheet. The system of real-time
PCR were 20 mL: 2 × qPCR Mixture 10 mL, upstream and
downstream primers 20 pmol respectively, cDNA 2 mL, double
distilled water 6 mL, with total volume of 20 mL. The ampliﬁ-
cation conditions of PCR were denaturation at 95 C for 10 s,
extension at 61 C for 45 s and 27 circulation in all. The
quantitative analysis was conducted by using the formula as the
follows: DCt = Ct1 − Ct2, where the Ct1was Ct value of target
gene and Ct2was Ct value of b-actin. The primer sequence was
as the follows:
b-Actin – forward: 50-GGGAAATCGTGCGTGACAT-30,
reverse: 50-CAGGAGGAGCAATGATCTT-30;ERK1 – forward: 50-TCCTTTGGATCTGGTCCTG-30,
reverse: 50-CCCCAGCAAGTGAGAGAAG-30;
ERK2 – forward: 50-AAGAGGTTGTTCCAAATGC-30,
reverse: 50-AGAGGCACCATTCACTGAC-30;
Caspase 3 – forward: 50-TACCACGCCAC-
CACCGGCCCA-30, reverse: 50-
GGCATTTTGGCTGTCGTCAGGGAA-30;
Caspase 9 – forward: 50-GGCGAATTGGAGATGAACTG-
30, reverse: 50-TTCTTCCAGATGGTGAGCGA-30;
Bax – forward: 50-CCCGAGAGGTCTTTTTCCGAG-30,
reverse: 50-CCAGCCCATGATGGTTCTGAT-30;
Bcl2 – forward 1: 50-ATGTGTGTGGAGAGCGTCAA-30,
reverse: 50-ACAGTTCCACAAAGGCATCC-30;
Ras – forward: 50-GGATTTGATGCCTTGGGAGTCA-
GAC-30, reverse: 50-ATTTTTTTCTTTGGAGTCAGTC-
CAT-30;
Raf – forward: 50-AAGATGGTACAGTGGACGGC-30,
Primer2: 50-CCGTGTTCCTGGTGAAATCT-30;
MEK – forward: 50-GACGACCAGTGGGGAGAGTA-30;
reverse: 50-GTCATTGAGCCGACCTAA-30.
2.5. Protein expression determined by Western blot
After treatment of SW620 cell lines, sterile phosphate buff-
ered saline buffer solution was used for washing 3 times for
10 min a time, and a homogenate was made in 0 C ice-water
bath. Coomassie brilliant blue method was used for quantiﬁca-
tion of total proteins. The mixture of extractive and loading
buffer at 1:4 ratio was boiled for 5 min and then equivalent
protein was gone through vertical sodium dodecyl sulfate-
polyacrylamide gelelectrophoresis protein electrophoresis. Af-
ter the electrophoresis, semi-dry transfer membrane was con-
ducted. After the protein was transferred to nitrocellulose
membrane, fetal calf serum was used to seal it. Then, mono-
clonal primary antibody was added at the dilution rate of 1:250
and cultured at room temperature for 6 h. The sterile phosphate
buffered saline buffer solution was used for washing 3 times,
after which second antibody was added (1:200) for reaction at
room temperature for 2 h. The quantitative analysis of relative
proteins was conducted with b-actin as the reference.
2.6. Statistical analysis
Data were analyzed by using SPSS19.0 software. One-way
ANOVA was used for measurement data which were expressed
as mean ± SD. c2 test was used for enumeration data. Differences
with P < 0.05 were considered as statistically signiﬁcant.3. Results
3.1. Inhibition effect of resveratrol on SW620
proliferation
It was found that cell proliferation was effectively inhibited
after treatment of MEK inhibitor PD98059 and resveratrol and
that the inhibition rate was increased along with the increasing
processing time (P < 0.05). Meanwhile, the inhibition effect of
resveratrol showed a dose-dependent manner (P < 0.01 or
P < 0.05) (Table 1).
Table 1
Inhibition effect of resveratrol on SW620 proliferation.
Groups % Inhibition rate
24 h 36 h 48 h 72 h
PD98059
group
18.7 ± 3.6## 23.8 ± 4.5*## 28.9 ± 4.8**## 39.9 ± 5.1**##
Low-dose
resveratrol
group
2.2 ± 0.4 3.5 ± 0.9 6.7 ± 1.3* 7.9 ± 1.8*
Mid-dose
resveratrol
group
7.5 ± 1.5# 8.6 ± 1.7*# 9.7 ± 1.9**# 12.1 ± 2.4**#
High-dose
resveratrol
group
16.8 ± 3.3## 19.7 ± 3.4*## 22.4 ± 4.2**## 30.8 ± 4.7**##
*: P < 0.05 compared with the inhibition rates at 24 h.
**: P < 0.01 compared with the inhibition rates at 24 h.
#: P < 0.05 compared with the inhibition rates in low-dose resveratrol group.
##:P < 0.01 compared with the inhibition rates in low-dose resveratrol group.
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real-time PCR
It was found that compared with control group, mRNA
expression of Bax, Caspase 3 and Caspase 9 after treatment of
PD98059 and resveratrol was signiﬁcantly increasedwhilemRNA
expression of anti-apoptotic molecule Bcl2 protein was signiﬁ-
cantly decreased (P < 0.05). Furthermore, the regulation effect of
resveratrol on mRNA expression of relative apoptotic molecules
showed a dose-dependentmanner (P< 0.01 orP< 0.05) (Table 2).Table 2
Change in expression of apoptotic molecules by real-time PCR (△Ct).
Groups Bax
Control group 6.03 ± 0.88 7.1
PD98059 group 7.55 ± 1.04**## 6.0
Low-dose resveratrol group 6.07 ± 1.11 6.8
Mid-dose resveratrol group 6.54 ± 1.08*# 6.3
High-dose resveratrol group 7.28 ± 1.14**## 6.1
*: P < 0.05 compared with control group.
**: P < 0.01 compared with control group.
#: P < 0.05 compared with low-dose resveratrol group.
##: P < 0.01 compared with low-dose resveratrol group.
Table 3
Change in expression of MEK/ERK molecules by real-time PCR (△Ct).
Groups Ras Raf
Control group 6.78 ± 1.07 6.98 ± 1.15
PD90059 group 5.69 ± 0.91**## 6.22 ± 1.24**##
Low-dose resveratrol group 6.81 ± 1.18 6.91 ± 0.19
Mid-dose resveratrol group 5.88 ± 1.19*# 6.51 ± 1.33*#
High-dose resveratrol group 5.73 ± 1.02**## 6.24 ± 1.11**##
*: P < 0.05 compared with control group.
**: P < 0.01 compared with control group.
#: P < 0.05 compared with low-dose resveratrol group.
##: P < 0.01 compared with low-dose resveratrol group.3.3. mRNA expression of MEK/ERK molecules by real-
time PCR
Compared with control group, the mRNA expression of
PD98059 and resveratrol–treated MEK/ERK signaling pathway
molecules Ras, Raf, MEK and ERK protein molecule was
signiﬁcantly decreased (P < 0.05). In addition, the regulation
effect of resveratrol on mRNA expression of proteins in MEK/
ERK signaling pathway showed a dose-dependent manner
(P < 0.01 or P < 0.05) (Table 3).Bcl2 Caspase 3 Caspase 9
7 ± 1.01 6.39 ± 1.04 7.50 ± 1.31
1 ± 1.04**## 7.14 ± 1.22**## 7.97 ± 1.24**##
8 ± 1.17 6.41 ± 1.12 7.52 ± 1.34
5 ± 1.04*# 6.55 ± 1.37*# 7.88 ± 1.59*#
1 ± 0.99**## 6.89 ± 1.24**## 8.12 ± 1.14**##
MEK ERK1 ERK2
7.87 ± 1.32 7.91 ± 1.01 7.88 ± 1.14
6.66 ± 1.26**## 7.06 ± 1.24**## 7.06 ± 1.11**##
7.34 ± 1.55 8.03 ± 1.29 7.89 ± 1.51
6.87 ± 1.24*# 7.67 ± 1.43*# 7.57 ± 1.33*#
6.69 ± 1.33**## 7.08 ± 1.45**## 7.10 ± 1.24**##
Table 4. Expression of apoptotic proteins after different drug treatments in colon cancer cells by Western Blotting analysis (%).
Groups Caspase 3 Caspase 9 Ras Raf MEK ERK1/2
Control group 0.38 ± 0.03 0.34 ± 0.03 0.82 ± 0.07 0.78 ± 0.07 0.82 ± 0.07 0.81 ± 0.07
PD90059 group 0.90 ± 0.06**## 0.84 ± 0.07**## 0.35 ± 0.03**## 0.36 ± 0.03**## 0.28 ± 0.02**## 0.25 ± 0.02**##
Low-dose resveratrol group 0.39 ± 0.04 0.36 ± 0.04 0.71 ± 0.06 0.77 ± 0.06 0.78 ± 0.06 0.82 ± 0.08
Mid-dose resveratrol group 0.59 ± 0.05*# 0.56 ± 0.05*# 0.52 ± 0.05*# 0.50 ± 0.04*# 0.50 ± 0.04*# 0.57 ± 0.05*#
High-dose resveratrol group 0.85 ± 0.07**## 0.80 ± 0.07**## 0.39 ± 0.04**## 0.40 ± 0.03**## 0.43 ± 0.04**## 0.45 ± 0.04**##
*: P < 0.05 compared with control group.
**: P < 0.01 compared with control group.
#: P < 0.05 compared with low-dose resveratrol group.
##: P < 0.01 compared with low-dose resveratrol group.
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Ras, Raf, MEK and ERK1/2 in PD98059 and
resveratrol–treated SW60 cells by Western blotting
Compared with control group, the expression of proteins
Caspase 3 and Caspase 9 was signiﬁcantly increased after the
treatment of PD98059 and resveratrol, with statistically signiﬁ-
cant difference (P < 0.05). The expression level of Caspase3 and
Caspase9 was higher when the dose of resveratrol increased.
Compared with control group, the contents of PD98059 and
resveratrol–treated MEK/ERK signaling pathway protein mole-
cules Ras, Raf, MEK and ERK1/2 were signiﬁcantly decreased,
showing statistically signiﬁcant difference between groups (P <
0.05). The expression level of Ras, Raf, MEK and ERK1/2
lowered as the dose of resveratrol increased (Table 4).
4. Discussion
At the present, colon cancer is one of the most clinically
common malignant tumors in department of gastroenterology,
with increasing morbidity and mortality year by year [7–9].
Nevertheless, the pathogenesis of colon cancer still remains
unclear for now and there are no efﬁcient drugs clinically. The
present study analyzed the mechanism of MEK/ERK signaling
pathway in the apoptosis of SW620 cells and the inhibition
effect of resveratrol on cell proliferation, and it is found that
compared with control group, the proliferation of cell treated
with resveratrol is apparently inhibited, expression of apoptotic
molecules Bax, Caspase 3 and Caspase 9 is signiﬁcantly
increased while expression of anti-apoptotic molecule Bcl2 is
signiﬁcantly decreased, expression of molecules Ras, Raf, MEK,
ERK in the MEK/ERK signaling pathway is signiﬁcantly
increased and that the effect of resveratrol shows a dose-
dependent manner. Therefore, PD98059 and resveratrol can
effectively inhibit the proliferation of SW620 and the inhibition
process might be achieved through inhibiting MEK/ERK
signaling transduction pathway.
Cell proliferation and apoptosis is the important clue in
treating malignant tumors, and also the main action mechanism of
antineoplastic drugs clinically at the present [10–12]. Cell apoptosis
is the ubiquitous physiological process in cells, but turns to be
weak in the cells of tumor issue [13–15]. Some apoptosis
proteins participate in the regulation of cell apoptosis such as
Bax, Caspase protein family, and so forth [16–19]. Increase in
protein expression of apoptotic cells usually induces the
occurrence of cell apoptosis [20–22]. In the research on induction
of tumor cell apoptosis by F2/SARI, it is found that drugs
promote the apoptosis of tumor cells mainly by inhibiting
NFkB and the activity of transcription factor AP1 [23]. In the
research on antitumor mechanism of auriculoside A metabolicproduct, it is found that drugs possess prominent antineoplastic
effect and the main action mechanism is to promote the
apoptosis process of tumor cells [24]. It is found in the present
study that SW620 cells treated with MEK inhibitor PD98059
and resveratrol show proliferation inhibition of different levels,
expression of apoptotic proteins Bax, Caspase 3 and Caspase 9
is signiﬁcantly increased while the expression of anti-apoptotic
protein Bcl2 is signiﬁcantly decreased, the proliferation inhibi-
tion rate is gradually increased with increasing reaction time and
that the proliferation inhibition effect of resveratrol shows a dose-
dependent manner, suggesting that resveratrol can inhibit the
proliferation of tumor cells by promoting the occurrence of cell
apoptosis.
MEK/ERK signaling transduction pathway is the main
pathway for transduction of extracellular signals into cells, with
participation in pathological and physiological processes of tu-
mors, like proliferation, differentiation, migration, apoptosis and
so on [25–27]. In the research on analysis of PI3K/AKT/ERK
signaling transduction pathway in expression of gastroenteric
tumor and clinicopathological correlation, it is found that though
ERK protein has nothing to do with the clinical pathology of
tumors, its high expression in tumor tissue participates in the
occurrence and development of gastroenteric tumor at early
stage [28]. In the research on effect of ERK pathway inhibitor
sodium phenylacetate on salivary gland tumors in transgenic
rats, it found the signiﬁcantly increasing expression of proteins
ERK1/2 and ph-ERK1/2 in tumor tissue, improvement in ERK
pathway proteins after intervention of sodium phenylacetate, and
tumor type in the tendency of benignization, suggesting that
participation of ERK in the occurrence and development of tumors
and the possibility of being one of the targets in drug therapy [29].
Wu et al. found that novel thiazolo-triazin compound R001 can
inhibit proliferation of tumor cells by inhibiting expression of ERK
signaling pathway proteins [30]. Accorded with the previous
researches, it is revealed in the present study that compared with
control group, expression of protein molecules Ras, Raf, MEK
and ERK1/2 in MEK/ERK signaling pathway treated with MEK
inhibitor PD98059 and resveratrol is signiﬁcantly decreased,
with statistically signiﬁcant difference, and meanwhile, that the
regulation effect of resveratrol on Ras and Raf shows a dose-
dependent manner, suggesting that resveratrol can inhibit prolif-
eration of colon cancer cells and promote the apoptosis of the tu-
mor cells by inhibiting the activation of ERK signaling pathway.
In conclusion, PD98059 and resveratrol can effectively
inhibit the proliferation of SW620, possibly by inhibiting MEK/
ERK signaling transduction pathway.
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